Holen Sie sich die Stockscreener-App
358.29
1.14%
-4.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$362.42
Offen:
$361.7
24-Stunden-Volumen:
2.00M
Relative Volume:
1.10
Marktkapitalisierung:
$137.02B
Einnahmen:
$25.12B
Nettoeinkommen (Verlust:
$3.25B
KGV:
42.64
EPS:
8.4018
Netto-Cashflow:
$4.28B
1W Leistung:
-3.05%
1M Leistung:
-2.21%
6M Leistung:
-4.44%
1J Leistung:
-9.54%
1-Tages-Spanne:
$354.48
$364.81
1-Wochen-Bereich:
$354.48
$371.90
52-Wochen-Spanne:
$329.16
$404.14
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
358.29 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
ABT
Abbott Laboratories
|
110.83 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
MDT
Medtronic Plc
|
102.90 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.27 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.71 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Stryker Corporation $SYK Shares Sold by Twin Capital Management Inc. - MarketBeat
Stryker Corp(SYK.US) Director Sells US$181.72 Million in Common Stock - 富途牛牛
Insider Selling: Stryker (NYSE:SYK) Director Sells 250,000 Shares of Stock - MarketBeat
Stryker Ronda E sells Stryker Corp (SYK) stock worth $181.7 million - Investing.com
Orthopedic Implants Market Size to Reach USD 33.20 Billion by 2033, Driven by Rising Musculoskeletal Disorders and Surgical Innovation – SNS Insider - GlobeNewswire Inc.
J.W. Cole Advisors Inc. Trims Stock Position in Stryker Corporation $SYK - MarketBeat
Bear Alert: Is Stryker Corporation in a bullish channelBreakout Watch & Accurate Technical Buy Alerts - baoquankhu1.vn
Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs - simplywall.st
Witnessing An Insider Decision, Spencer S Stiles Exercises Options Valued At $3.70M At Stryker - Benzinga
Stryker tops $25B in revenue and signals confidence in 2026 growth - Crain's Grand Rapids Business
Stryker declares quarterly dividend of $0.88 per share - Investing.com
Stryker declares an $0.88 per share quarterly dividend - The Globe and Mail
Jones Financial Companies Lllp Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker group president Pierce sells $175k in shares By Investing.com - Investing.com South Africa
Stryker group president Pierce sells $175k in shares - Investing.com
10 Best Health Care Stocks to Buy for 2026 - US News Money
Stryker Corporation $SYK Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Morgan Stanley Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $445 - 富途牛牛
Stryker Corporation (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Atle Fund Management AB Has $8.42 Million Stake in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Earnings Call Highlights Growth and Resilience - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $387 to $465 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript - Insider Monkey
Stryker raises annual profit forecast on strong sales for medical devices - Reuters
Assessing Stryker (SYK) Valuation After Strong Results And Optimistic 2026 Growth Outlook - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $412 to $454 - 富途牛牛
Piper Sandler Maintains Overweight Rating on Stryker Corporation (SYK) - Finviz
Stryker starts first cases with handheld ortho robot - MedTech Dive
Stryker (NYSE:SYK) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Stryker stock price target raised to $412 from $410 at BTIG By Investing.com - Investing.com South Africa
Evercore ISI Adjusts Stryker Price Target to $400 From $390, Maintains Outperform Rating - marketscreener.com
BTIG Research Adjusts Stryker Price Target to $412 From $410, Maintains Buy Rating - marketscreener.com
Needham raises Stryker stock price target to $454 on strong Q4 results By Investing.com - Investing.com South Africa
Barclays Adjusts Stryker Price Target to $469 From $462, Maintains Overweight Rating - marketscreener.com
Stryker (NYSE:SYK) Given New $454.00 Price Target at Needham & Company LLC - MarketBeat
Needham raises Stryker stock price target to $454 on strong Q4 results - Investing.com
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target By Investing.com - Investing.com India
Stryker (NYSE:SYK) Issues FY 2026 Earnings Guidance - MarketBeat
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target - Investing.com
Stryker rises after raising annual profit forecast - TradingView
Stryker enters 2026 with ‘strong momentum’ after FY25 revenue eclipses $25bn - Yahoo Finance
Knights of Columbus Asset Advisors LLC Has $8.95 Million Holdings in Stryker Corporation $SYK - MarketBeat
Stryker price target raised to $412 from $410 at BTIG - TipRanks
Pittenger & Anderson Inc. Acquires 11,827 Shares of Stryker Corporation $SYK - MarketBeat
Tandem Investment Advisors Inc. Acquires 7,425 Shares of Stryker Corporation $SYK - MarketBeat
The Analyst Verdict: Stryker In The Eyes Of 11 Experts - Benzinga
Stryker stock rating reiterated at Market Outperform by Citizens - Investing.com
Stryker (SYK) Receives Price Target Increase from Needham | SYK Stock News - GuruFocus
Stryker Corporation $SYK Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
BTIG Raises Price Target for Stryker (SYK) to $412 Following Ana - GuruFocus
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):